IPAD-DB ID | C00327 |
Name | Obtusin |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 8 H 1 6 O 7 |
Molecular Weight | 344.3g/mol |
IUPAC Name | 1, 7-dihydroxy-2, 3, 8-trimethoxy-6-methylanthracene-9, 10-dione |
InChI | InChI=1S/C18H16O7/c1-7-5-8-12(18(25-4)13(7)19)15(21)11-9(14(8)20)6-10(23-2)17(24-3)16(11)22/h5-6, 19, 22H, 1-4H3 |
InChIKey | CFLNHFUPWNRWJA-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC2=C(C(=C1O)OC)C(=O)C3=C(C(=C(C=C3C2=O)OC)OC)O |
PubChem CID | 155380 |
DrugBank Accession Number | - |
CAS Registry Number | 70588-05-5 |
Molecular Weight(Computed by SwissADME) | 344.32 |
Hac(Computed by SwissADME) | 25 |
Volume(Computed by ADMETlab 2.0) | 334.655 |
Density(Computed by ADMETlab 2.0) | 1.028 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 7 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 18 |
Flexibility(Computed by ADMETlab 2.0) | 0.167 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -4.269 |
LogD(Computed by ADMETlab 2.0) | 2.287 |
logP(Computed by ADMETlab 2.0) | 2.21 |
TPSA(Computed by SwissADME) | 102.29 Ų |
Hbond Acceptor(Computed by SwissADME) | 7 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.28 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | Yes |
Bioavailability Score(Computed by SwissADME) | 0.55 |